Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Gordon Scott has been an active investor and ...

Our teacher already knows there is a positive relationship between how much time was spent on an essay and the grade the essay gets, but we’re going to need some data to demonstrate this properly.

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Vikki Velasquez is a researcher and writer ...

Fruchter, G. (2026) Opportunism in Supply Chain Recommendations: A Dynamic Optimization Approach. Modern Economy, 17, 26-38.

An equation of the form \(y = mx + c\) where \(m\) and \(c\) are numbers, gives a straight line when values of \(x\) and corresponding values of \(y\) are plotted on a grid. A straight line is a ...

More than a century after Srinivasa Ramanujan scribbled his astonishing formulas for π in notebooks in India and England, ...